TBC1D3H inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the TBC1D3H protein, a member of the TBC1 domain family. Proteins in the TBC1 domain family are known for their involvement in regulating intracellular trafficking, particularly in the recycling and degradation of membrane-bound proteins, including receptors and transporters. TBC1D3H, like other TBC1 proteins, is thought to function as a GTPase-activating protein (GAP), which regulates the activity of small GTPases involved in endosomal sorting and vesicular transport. By inhibiting TBC1D3H, these compounds interfere with the protein's ability to regulate GTPase activity, thereby impacting processes related to membrane trafficking, endocytosis, and the recycling of receptors within the cell.
Research into TBC1D3H inhibitors is important for understanding how intracellular trafficking is regulated by TBC1 family proteins, particularly in relation to their role in modulating cellular communication and signal transduction. Inhibition of TBC1D3H provides a valuable tool for studying how disruptions in membrane trafficking pathways affect cellular processes such as receptor recycling, cargo sorting, and vesicular transport. By exploring the effects of TBC1D3H inhibition, researchers can gain insights into the broader network of proteins involved in intracellular transport and how these networks contribute to maintaining cellular homeostasis. Additionally, TBC1D3H inhibitors help elucidate the specific role of this protein in regulating the spatial and temporal control of GTPase activity, which is crucial for the proper functioning of various cellular compartments. This class of inhibitors thus provides a deeper understanding of the molecular mechanisms governing intracellular dynamics and protein trafficking.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
This chemical acts as a PI3K inhibitor, and since TBC1D3H is implicated in the PI3K/AKT signaling pathway, wortmannin can inhibit this pathway, possibly reducing the protein's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Similar to wortmannin, LY294002 inhibits PI3K, which is part of the signaling cascade that TBC1D3H may participate in, leading to a decrease in its functional activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, rapamycin suppresses the mTOR pathway, which can interact with signaling pathways involving TBC1D3H, thereby reducing its downstream effects. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
By inhibiting both mTORC1 and mTORC2, PP242 can affect pathways associated with TBC1D3H, potentially inhibiting the protein's effects on cell growth and survival. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This chemical is a MEK inhibitor, which could affect MAPK/ERK pathway signaling. If TBC1D3H is involved in this pathway, PD98059 can suppress its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, SP600125 can modulate signaling pathways that may be linked to TBC1D3H's function, leading to altered protein activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 targets p38 MAPK, which can influence stress response pathways. If TBC1D3H is related to these pathways, the chemical can inhibit its activity. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
This AKT inhibitor can suppress AKT signaling, which may be related to TBC1D3H's role in cell survival and growth, leading to reduced activity of the protein. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
By inhibiting Aurora kinases, ZM-447439 can affect cell cycle progression. If TBC1D3H is involved in cell cycle regulation, its activity can be inhibited. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
This FGFR inhibitor can affect growth factor signaling, potentially influencing pathways that TBC1D3H is part of, leading to an inhibition of its activity. | ||||||